EP25-336-23 Supplemental oxygen in Queen Elizabeth Central Hospital Malawi: a prospective cohort study of patients admitted to medical wards

H Thomson, M Mlaviwa, Jamie Rylance, H Jones, R Wang, M Reuben, M Stolbrink

Research output: Contribution to conferencePaper

Abstract

Background: Oxygen is listed as an essential drug by the World Health Organisation and has been shown to reduce mortality in the context of hypoxia. In low-re- source settings the provision of oxygen seldom meets the demand. This study aims to explore the predictors and the observed time-course of hypoxaemia, and thus bet- ter rationalize distribution of oxygen therapy in lower- middle income countries.

Design/Methods: We conducted a prospective cohort study of adults with hypoxaemia that received oxygen therapy and were admitted to medical wards at a teach- ing hospital in Malawi between January and March 2020. Vital signs and oxygen therapy were recorded dai- ly. Study end-points were death, discharge from hospital or continued inpatient at day 14. Kaplan-Meier and Cox regression analysis was used for time-to-event analysis. Results: 33 patients were included in the study (median age 45years [interquartile range (IQR) 33-61years]). The median oxygen saturations at initiation of oxygen ther- apy was 84% (IQR

Original languageEnglish
PagesS290
Publication statusPublished - 23 Oct 2020

Fingerprint

Dive into the research topics of 'EP25-336-23 Supplemental oxygen in Queen Elizabeth Central Hospital Malawi: a prospective cohort study of patients admitted to medical wards'. Together they form a unique fingerprint.

Cite this